Search research articles
Contact Us
Filters
Showing results (81-90 of 361) with videos related to
Page
of 37
Sort By:
Advances in Pharmacology (San Diego, Calif.)
|
January 1, 1994
Mechanism of action of topoisomerase II-targeted antineoplastic drugs
N Osheroff, A H Corbett, M J Robinson
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
March 6, 2025
Built differently or defective: can RNA exosomopathies cause ribosome heterogeneity?
Zachary J Bressman, Anita H Corbett, Homa Ghalei
Traffic (Copenhagen, Denmark)
|
July 15, 2015
Mechanisms Regulating Protein Localization
Nicholas C Bauer, Paul W Doetsch, Anita H Corbett
Cancer Research
|
July 1, 1987
Response-specific adriamycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas
J L Evelhoch, N A Keller, T H Corbett
Cell and Tissue Kinetics
|
November 1, 1980
The cell population kinetics and response to an S-phase specific agent of three transplantable colon tumor lines
L Simpson-Herren, T H Corbett, D P Griswold
Molecular Biology of the Cell
|
August 10, 2000
The interaction between Ran and NTF2 is required for cell cycle progression
B B Quimby, C A Wilson, A H Corbett
Wiley Interdisciplinary Reviews. RNA
|
March 10, 2025
Post-Transcriptional Regulation of Gene Expression and the Intricate Life of Eukaryotic mRNAs
Carly L Lancaster, Kenneth H Moberg, Anita H Corbett
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 21, 2012
Implementation of targeted interventions to decrease antiretroviral-related errors in hospitalized patients
Lindsay M Daniels, Ralph H Raasch, Amanda H Corbett
Plant Physiology
|
January 24, 2006
Identification and characterization of the Arabidopsis orthologs of nuclear transport factor 2, the nuclear import factor of ran
Qiao Zhao, Sara Leung, Anita H Corbett, et al.
Investigational New Drugs
|
January 1, 1987
Is the P388 murine tumor no longer adequate as a drug discovery model?
T H Corbett, F A Valeriote, L H Baker
Page
of 37
Search research articles
Search
Showing results (81-90 of 361) with videos related to
Sort By:
Page
of 37
Advances in Pharmacology (San Diego, Calif.)
|
January 1, 1994
Mechanism of action of topoisomerase II-targeted antineoplastic drugs
N Osheroff, A H Corbett, M J Robinson
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
March 6, 2025
Built differently or defective: can RNA exosomopathies cause ribosome heterogeneity?
Zachary J Bressman, Anita H Corbett, Homa Ghalei
Traffic (Copenhagen, Denmark)
|
July 15, 2015
Mechanisms Regulating Protein Localization
Nicholas C Bauer, Paul W Doetsch, Anita H Corbett
Cancer Research
|
July 1, 1987
Response-specific adriamycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas
J L Evelhoch, N A Keller, T H Corbett
Cell and Tissue Kinetics
|
November 1, 1980
The cell population kinetics and response to an S-phase specific agent of three transplantable colon tumor lines
L Simpson-Herren, T H Corbett, D P Griswold
Molecular Biology of the Cell
|
August 10, 2000
The interaction between Ran and NTF2 is required for cell cycle progression
B B Quimby, C A Wilson, A H Corbett
Wiley Interdisciplinary Reviews. RNA
|
March 10, 2025
Post-Transcriptional Regulation of Gene Expression and the Intricate Life of Eukaryotic mRNAs
Carly L Lancaster, Kenneth H Moberg, Anita H Corbett
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 21, 2012
Implementation of targeted interventions to decrease antiretroviral-related errors in hospitalized patients
Lindsay M Daniels, Ralph H Raasch, Amanda H Corbett
Plant Physiology
|
January 24, 2006
Identification and characterization of the Arabidopsis orthologs of nuclear transport factor 2, the nuclear import factor of ran
Qiao Zhao, Sara Leung, Anita H Corbett, et al.
Investigational New Drugs
|
January 1, 1987
Is the P388 murine tumor no longer adequate as a drug discovery model?
T H Corbett, F A Valeriote, L H Baker
Page
of 37